In addition, cluster analysis based on 24 clinical and serologic variables performed in 6,927 SSc patients revealed six homogeneous groups, which differed with regard to their clinical features, ANA profile, and mortality, with distinct prognosis. The gene discussed is BTG3; the disease is systemic sclerosis.